SMNH Development Pipeline

product pipeline

* Phase 1 trial in indication not conducted.

Based on our proprietary platform technology, we are building a strong pipeline of SMNH compounds with a wide range of applications. We plan to focus on the development of our most advanced product candidate, SB 9200, for the treatment of hepatitis B virus (“HBV”).

iStock_000004418525XSmall

Ongoing Clinical Trials

Get Details

SMNH Compounds